Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Carole Galligan"'
Autor:
Kim Margolin, Victoria Atkinson, Charlotte Lemech, Philippe Bedard, Przemyslaw Twardowski, Sajeve Thomas, Amy Prawira, Arash Yavari, Peter Lloyd, Warren Brenner, Rosemina Merchant, Carole Galligan, Fahar Merchant, Minh D To, Melissa Coello, Jesus Fuentes Antras, Sudhir Madduri Karanam, Matthen Mathew
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/35f9e53ab7a7412d9e51e22573e86762
Autor:
Paul Smith, Peter Lloyd, Rosemina Merchant, Carole Galligan, Manjunatha Ankathatti Munegowda, L Bruce Pearce, Fahar Merchant, Minh D To
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/3a63f38332b04f0d90cd8a5177f8a6c0
Autor:
Minh To, Nina Merchant, Melissa Coello, Carole Galligan, Kritika Mehta, Victoria Atkinson, Martin Bexon, Jim Coward, Jenny Lee, Charlotte Lemech, Peter Lloyd, Jesus Antras, Arash Yavari, Fahar Merchant
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::568a6143a2940c4403d18fd827640c6e
https://doi.org/10.1136/jitc-2022-sitc2022.0743
https://doi.org/10.1136/jitc-2022-sitc2022.0743
Autor:
Minh D. To, Fahar Merchant, Ma'an Muhsin, Carole Galligan, L. Bruce Pearce, Peter Lloyd, Rosemina Merchant
Publikováno v:
Molecular Cancer Therapeutics. 20:P198-P198
Background: MDNA11 is an engineered ‘beta-only’ IL-2 superkine with (1) enhanced affinity for IL-2Rb (CD122) to preferentially activate anti-cancer effector immune cells and (2) extended half-life by fusion to human albumin, avoiding the need for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::356e9a5de15404e0dd0ae9605df2d646
https://doi.org/10.1158/1535-7163.targ-21-p198
https://doi.org/10.1158/1535-7163.targ-21-p198
Autor:
Natasja Nielsen Viller, Laura Brinen, Zezhou Wang, Tina Catalano, Carole Galligan, Karen Dodge, Simone Helke, Robert A. Uger, Vivian S. Lee, Bolette Bossen, Peter Dove, Jeff Winston, Mark Wong, Gloria H. Y. Lin, Malik Slassi, David A. Rosa, Marilyse Charbonneau
Publikováno v:
Cancer Research. 79:3854-3854
The cGAS-STING pathway plays a pivotal role in sensing aberrant cytoplasmic DNA fragments derived from pathogens or host tumor cells and initiating an innate immune response. STING activation induces type I IFNs and a cascade of other pro-inflammator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4c3d0d15226d88d435d4c73a8135cb5
https://doi.org/10.1158/1538-7445.am2019-3854
https://doi.org/10.1158/1538-7445.am2019-3854
Autor:
O.M. Howard, Carole Galligan
Publikováno v:
Current pharmaceutical design. 10(19)
The contribution of small molecular weight chemoattractant cytokines (chemokines) and their receptors in the trafficking of tumor, immune and vascular cells pertaining to the development and progression of cancer has begun to be investigated. The cur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::827a716cd50c0949e778abd52612ee99
https://pubmed.ncbi.nlm.nih.gov/15279615
https://pubmed.ncbi.nlm.nih.gov/15279615
Publikováno v:
The Journal of Immunology. 182:131.3-131.3
Anti-influenza type 2 (T2) immunity contributes to both immunoprotection and immunopathology, yet the underlying mechanisms modulating T2 immunity remain ill-defined. Here, we describe a novel murine antigen (Ag) presenting cell (APC) population, des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10317ec5566ba3e70ea1acbb667958f5
https://doi.org/10.4049/jimmunol.182.supp.131.3
https://doi.org/10.4049/jimmunol.182.supp.131.3